🔗 Visit the ClinicalTrials.gov page for NCT00563173
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C. | Mol Ther | 2013 | 0.96 |
| 2 | Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen. | Genet Vaccines Ther | 2009 | 0.93 |
| 3 | Synthetic DNA vaccine strategies against persistent viral infections. | Expert Rev Vaccines | 2013 | 0.92 |